Answers are grounded in this paper and cite their sources.
The sulphilimine cross-link of the Goodpasture (GP) autoantigen is a novel molecular mechanism (structural constraint) for conferring immune privilege to a site which otherwise is susceptible to structural changes that induce an immunogenic and pathogenic conformation. Perturbation of the assembly or cleavage of the sulphilimine cross-links could be a key factor in the aetiology of Goodpasture's disease in susceptible individuals.
No takes yet. Share an insight, caveat, or question.
Vanacore et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: